| Literature DB >> 32930628 |
Pourya Gholizadeh1, Mohammad Aghazadeh2, Reza Ghotaslou2, Mohammad Ahangarzadeh Rezaee2, Tahereh Pirzadeh2, Şükran Köse3, Khudaverdi Ganbarov4, Mehdi Yousefi5,6, Hossein Samadi Kafil1.
Abstract
Enterococcus faecalis is one of the important causative agents of nosocomial and life-threatening infections in human. Several studies have demonstrated that the presence of CRISPR-cas is associated with antibiotic susceptibility and lack of virulence traits. In this study, we aimed to assess the phenotypic and genotypic virulence determinants in relation to CRISPR elements from the dental-root canals and hospital-acquired isolates of E. faecalis. Eighty-eight hospital-acquired and 73 dental-root canal isolates of E. faecalis were assessed in this study. Phenotypic screening of the isolates included biofilm formation, and gelatinase and hemolysis activities. Genotypical screening using PCR was further used to evaluate the presence of CRISPR elements and different virulence-associated genes such as efaA, esp, cylA, hyl, gelE, ace, ebpR, and asa1. Biofilm formation, gelatinase, and hemolysis activities were detected in 93.8%, 29.2%, and 19.2% of the isolates, respectively. The most prevalent virulence-associated gene was ace, which was followed by efaA, whereas cylA was the least identified. The presence of CRISPR1-cas, orphan CRISPR2, and CRISPR3-cas was determined in 13%, 55.3%, and 17.4% of the isolates, respectively. CRISPR elements were significantly more prevalent in the dental-root canal isolates. An inverse significant correlation was found between CRISPR-cas loci, esp, and gelE, while direct correlations were observed in the case of cylA, hyl, gelE (among CRISPR-loci 1 and 3), asa1, ace, biofilm formation, and hemolysis activity. Findings, therefore, indicate that CRISPR-cas might prevent the acquisition of some respective pathogenicity factors in some isolates, though not all; so selective forces could not influence pathogenic traits. Abbreviations: BHI: brain-heart infusion agar; CRISPRs: Clustered regularly interspaced short palindromic repeats; Esp: Cell wall-associated protein; ENT: ear-nose-throat; ICU: intensive care units; OD: optical densities; PCR: polymerase chain reaction; SDS: sodium dodecyl sulfate; UTI: urinary tract infection.Entities:
Keywords: Enterococcus faecalis ; CRISPR-Cas system; dental-root canal bacteria; hospital-acquired bacteria; phenotypic characteristics; virulence genes
Mesh:
Substances:
Year: 2020 PMID: 32930628 PMCID: PMC7549939 DOI: 10.1080/21505594.2020.1809329
Source DB: PubMed Journal: Virulence ISSN: 2150-5594 Impact factor: 5.882
Primers used for the detection of virulence genes and CRISPR-associated genes.
| Gene | Primer | Sequence (5ʹ–3ʹ) | PCR product length (bp) | References |
|---|---|---|---|---|
| espF | GGAACGCCTTGGTATGCTAAC | 95 | [ | |
| espR | GCCACTTTATCAGCCTGAACC | |||
| cylF | ACTCGGGGATTGATAGGC | 688 | [ | |
| cylR | GCTGCTAAAGCTGCGCTT | |||
| hylF | ACAGAAGAGCTGCAGGAAATG | 276 | [ | |
| hylR | GACTGACGTCCAAGTTTCCAA | |||
| efaF | TGGGACAGACCCTCACGAATA | 101 | [ | |
| efaR | CGCCTGTTTCTAAGTTCAAGCC | |||
| gelF | TATGACAATGCTTTTTGGGAT | 213 | [ | |
| gelR | AGATGCACCCGAAATAATATA | |||
| aceF | GGAGAGTCAAATCAAGTACGTTGGTT | 101 | [ | |
| aceR | TGTTGACCACTTCCTTGTCGAT | |||
| ebpF | AAAAATGATTCGGCTCCAGAA | 101 | [ | |
| ebpR | TGCCAGATTCGCTCTCAAAG | |||
| asaF | GCACGCTATTACGAACTATGA | 375 | [ | |
| asaR | TAAGAAAGAACATCACCACGA | |||
| CRISPR1- | For | CAGAAGACTATCAGTTGGTG | 783 | [ |
| Rev | CCTTCTAAATCTTCTTCATAG | |||
| CRISPR1- | For | GCGATGTTAGCTGATACAAC | 315 | [ |
| Rev | CGAATATGCCTGTGGTGAAA | |||
| CRISPR2 loci | For | CTGGCTCGCTGTTACAGCT | variable | [ |
| Rev | GCCAATGTTACAATATCAAACA | |||
| CRISPR3- | For | GCTGAATCTGTGAAGTTACTC | 258 | [ |
| Rev | CTGTTTTGTTCACCGTTGGAT | |||
| CRISPR3- | For | GATCACTAGGTTCAGTTATTTC | 224 | [ |
| Rev | CATCGATTCATTATTCCTCCAA |
Figure 1.Biofilm formation absorbance by E. faecalis isolates according to the presence of virulence factors and CRISPR loci. (Error bars illustrate the minimum and maximum of three replicates of absorbance of the biofilm formation; *P-value was significant (P-value<0.05.)
Genotypic and phenotypic determinants of hospital-acquired and dental-root canal isolates.
| Gelatinase activity | Hemolysis | Biofilm formation | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Source | P ( | P ( | P ( | P ( | P ( | P ( | P ( | P ( | Positive ( | β | γ | N | + | ++ | +++ | |
| 73.9% (65) | 13.6% (12) | 15.9% (14) | 93.2% (82) | 37.5% (33) | 88.6% (78) | 79.5% (70) | 15.9% (14) | 39.8% (35) | 29.5% (26) | 5.7% (5) | 64.8% (57) | 4.5% (4) | 6.8% (6) | 20.5% (18) | 68.2% (60) | |
| UTIs (78) | 78.2% (61) | 15.4% (12) | 14.1% (11) | 93.6% (73) | 34.6% (27) | 89.7% (70) | 78.2% (61) | 16.7% (13) | 39.7% (31) | 29.5% (23) | 6.4% (5) | 64.1% (50) | 5.1% (4) | 3.8% (3) | 21.8% (17) | 69.2% (54) |
| Non-UTIs (10) | 40% (4) | 0 | 30% (3) | 90% (9) | 60% (6) | 80% (8) | 90% (9) | 10% (1) | 40% (4) | 30% (3) | 0 | 70% (7) | 0 | 30% (3) | 10% (1) | 60% (6) |
| 68.5% (55) | 0 | 24.7% (18) | 75.3% (55) | 19.2% (14) | 89% (65) | 84.9% (62) | 13.7% (10) | 16.4% (12) | 0 | 0 | 100% (73) | 8.2% (6) | 19.2% (14) | 26% (19) | 46.6% (34) | |
| 0.282 | <0.001 | 0.118 | 0.002 | 0.008 | 0.570 | 0.249 | 0.435 | 0.001 | <0.001 | 0.023 | ||||||
| 71.4% (115) | 7.5% (12) | 19.9% (32) | 85.1% (137) | 29.2% (47) | 88.8% (143) | 82% (132) | 14.9% (24) | 29.2% (47) | 16.1% (26) | 3.1% (5) | 80.7% (130) | 6.2% (10) | 12.4% (20) | 23% (37) | 58.4% (94) | |
UTIs, urinary tract infections; non-UTIs: other isolates containing wound and blood; P: presence; N: negative; α: alpha hemolysin; β: beta hemolysin; γ: none hemolysin; +: low; ++: moderate; +++: strong
§ One-tailed Fisher’s exact test was used for comparison of hospital-acquired and dental-root canal groups.
Figure 2.Biofilm formation absorbance association to virulence genes and CRISPR loci among E. faecalis isolates. (Error bars illustrate the minimum and maximum of three replicates of absorbance of the biofilm formation; *P-value was significant (P-value<0.05.)
Figure 3.Distribution of virulence gene counts among E. faecalis isolates.
The presence of CRISPR-cas type in hospital-acquired and dental-root isolates of E. faecalis.
| CRISPR | CRISPR1-cas | CRISPR2 | CRISPR3-cas | CRISPR1-cas or CRISPR2 | CRISPR1-cas or CRISPR3-cas | CRISPR2 or CRISPR3-cas | CRISPR1-cas and CRISPR2 | CRISPR1-cas and CRISPR3-cas | CRISPR2 and CRISPR3-cas | CRISPR1-cas and CRISPR2 and CRISPR3-cas |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospital-acquired isolates (88) | 19.3% (17) | 53.4% (47) | 2.3% (2) | 59.1% (52) | 21.6% (19) | 54.5% (48) | 13.6% (12) | 0 | 1.1% (1) | 0 |
| Dental root isolates (73) | 5.5% (4) | 57.5% (42) | 35.6% (26) | 58.9% (43) | 42.5% (31) | 72.6% (53) | 5.5% (4) | 0 | 20.5% (15) | 0 |
| 0.008 | 0.358 | <0.001 | 0.554 | 0.004 | 0.014 | 0.070 | NS | <0.001 | NS | |
| Total (161) | 13% (21) | 55.3% (89) | 17.4% (28) | 59% (95) | 31.1% (50) | 62.7% (101) | 9.9% (16) | 0 | 9.9% (16) | 0 |
NS, not significant.
§ One-tailed Fisher’s exact test was used for comparison of hospital-acquired and dental-root canal groups.
Figure 4.Virulence gene counts association to CRISPR loci among E. faecalis isolates. (Error bars illustrate the minimum and maximum of virulence gene counts; *P-value was significant (P-value <0.05; H: Hospital-acquired; D: Dental-acquired; T: Total).
Association between genotypic and phenotypic characteristics and the occurrence of CRISPR-cas in E. faecalis.
| Gene | CRISPR1-present | CRISPR1-absent | CRISPR2-present | CRISPR2-absent | CRISPR3-present | CRISPR3-absent | CRISPR1 or CRISPR2-present | CRISPR1 or CRISPR2-absent | CRISPR1 or CRISPR3-present | CRISPR1 or CRISPR3-absent | CRISPR2 or CRISPR3-present | CRISPR2 or CRISPR3-absent | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20 | 95 | 0.005 | 64 | 51 | 0.509 | 21 | 94 | 0.417 | 68 | 47 | 0.549 | 41 | 74 | 0.033 | 72 | 43 | 0.554 | |
| 1 | 45 | 25 | 21 | 7 | 39 | 27 | 19 | 9 | 37 | 29 | 17 | |||||||
| 4 | 8 | 0.053 | 6 | 6 | 0.464 | 0 | 12 | 0.092 | 7 | 5 | 0.594 | 4 | 8 | 0.544 | 6 | 6 | 0.258 | |
| 17 | 132 | 83 | 66 | 28 | 121 | 88 | 61 | 46 | 103 | 95 | 54 | |||||||
| 1 | 31 | 0.048 | 20 | 12 | 0.237 | 6 | 26 | 0.500 | 21 | 11 | 0.260 | 7 | 25 | 0.149 | 23 | 9 | 0.161 | |
| 20 | 109 | 69 | 60 | 22 | 107 | 74 | 55 | 43 | 86 | 78 | 51 | |||||||
| 20 | 117 | 0.139 | 75 | 62 | 0.461 | 22 | 115 | 0.214 | 81 | 56 | 0.557 | 43 | 94 | 0.518 | 86 | 51 | 0.575 | |
| 1 | 23 | 14 | 10 | 6 | 18 | 14 | 10 | 7 | 17 | 15 | 9 | |||||||
| 7 | 40 | 0.415 | 35 | 12 | 0.001 | 5 | 42 | 0.108 | 36 | 11 | 0.003 | 12 | 35 | 0.217 | 36 | 11 | 0.014 | |
| 14 | 100 | 54 | 60 | 23 | 91 | 59 | 55 | 38 | 76 | 65 | 49 | |||||||
| 20 | 123 | 0.282 | 84 | 59 | 0.012 | 26 | 117 | 0.358 | 89 | 54 | 0.019 | 46 | 97 | 0.285 | 94 | 49 | 0.027 | |
| 1 | 17 | 5 | 13 | 2 | 16 | 6 | 12 | 4 | 14 | 7 | 11 | |||||||
| 18 | 114 | 0.451 | 75 | 57 | 0.263 | 24 | 108 | 0.399 | 80 | 52 | 0.250 | 42 | 90 | 0.418 | 85 | 47 | 0.235 | |
| ebpR-absent | 3 | 26 | 14 | 15 | 4 | 25 | 15 | 14 | 8 | 21 | 16 | 13 | ||||||
| 6 | 18 | 0.067 | 15 | 9 | 0.293 | 3 | 21 | 0.363 | 17 | 7 | 0.146 | 9 | 15 | 0.303 | 16 | 8 | 0.425 | |
| 15 | 122 | 74 | 63 | 25 | 112 | 78 | 59 | 41 | 96 | 85 | 52 | |||||||
| Biofilm-positive | 19 | 132 | 0.384 | 86 | 65 | 0.092 | 27 | 124 | 0.453 | 91 | 60 | 0.176 | 46 | 105 | 0.377 | 97 | 54 | 0.117 |
| Biofilm-negative | 2 | 8 | 3 | 7 | 1 | 9 | 4 | 6 | 4 | 6 | 4 | 6 | ||||||
| Gelatinase-positive | 4 | 43 | 0.203 | 29 | 18 | 0.190 | 10 | 37 | 0.268 | 30 | 17 | 0.268 | 14 | 33 | 0.490 | 32 | 15 | 0.236 |
| Gelatinase-negative | 17 | 97 | 60 | 54 | 18 | 96 | 65 | 49 | 36 | 78 | 69 | 45 | ||||||
| Hemolysis-positive | 4 | 27 | 0.623 | 19 | 12 | 0.293 | 0 | 31 | 0.001 | 19 | 12 | 0.469 | 4 | 27 | 0.010 | 19 | 12 | 0.504 |
| Hemolysis-negative | 17 | 113 | 70 | 60 | 28 | 102 | 76 | 54 | 46 | 84 | 82 | 48 |